September Product News

Pharmacy Times
Volume 0

High Alert Piggyback Labels

EPS Inc (Ivyland, PA), in conjunction with hospital pharmacistsand nurses, has developed 4 new High Alert Piggyback Labels.The labels were designed to help practitioners call attentionto medication requiring special handling, both in the pharmacyand directlyat the patient's bedside.Each High AlertPiggyback Label (onefor heparin, insulin,epidural, and chemotherapymedications)measures 1½in x 3 in. The overalllabel contains a large, brightly colored, ½ in x 2½ in high alertlabel as well as 2 smaller 3/16 in x 2½ in intravenous (IV) linetracinglabels identifying the medication. In order to ensuresafety, the pharmacy places the overall 1½ in x 3 in label onthe IV infusion container or its overwrapped packaging. TheHigh Alert Piggyback Label also can be peeled from the largerlabel and placed directly on the IV medication. When the medicationis sent to the nursing station, the IV nurse peels the 2piggyback IV line-tracing labels and places them directly on theIV tubing. One label is placed on top of the line and the otherat the bottom. This facilitates easy line traces, improves accuracy,and minimizes IV line confusion. For more information,visit, or call 800-523-8966.

Heparin Sodium Injection, USP

APP Pharmaceuticals Inc (Schaumburg,IL) recently launchedenhanced labeling for its line of Heparin Sodium Injection, USP.The labels and cap colors for APP's heparin have incorporatedclearly differentiating color combinations since the companybegan marketing the product in 1998. The new labeling representsfurther enhancements to help differentiate HeparinSodium Injectionfrom other heparinproducts. HeparinSodium Injection,USP labels featuresimplified uprighttext and increasedfocus on a horizontalread of information;bolded andincreased font sizeby approximately200% for eachstrength; more vibrantcap and label colors for each strength; notations oftotal unit strength per mL and total volume; and bar codes atthe individual unit-of-use. For more information, visit, or call 888-386-1300.

Recent Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs